title: Impact of 5A/6A polymorphism of matrix metalloproteinase-3 on recurrent atherosclerotic ischemic stroke in Chinese.
abstract: Little is known about the impact of the 5A/6A polymorphism of matrix metalloproteinase-3 (MMP-3) on recurrence of atherosclerotic ischemic stroke in Chinese. The aim of this study was to investigate the association of MMP-3 serum level and 5A/6A genetic polymorphism with the recurrence of atherosclerotic ischemic stroke in the Chinese Han population. We analyzed 106 large artery atherosclerosis (LAA) recurrent ischemic stroke patients and 545 LAA first onset ischemic stroke patients from January 2009 to June 2014. Serum MMP-3 concentrations were measured with an enzyme-linked immunosorbent assay. The genotypes of MMP-3 promoter polymorphism (-1171 5A/6A) were determined using polymerase chain reaction-restriction fragment length polymorphism. The frequencies of MMP-3 5A/6A+5A/5A (32.08% vs. 21.47%, p = 0.02) genotype and 5A (16.98% vs. 11.01%, p = 0.01) allele in the recurrent group was significantly higher than those in the first onset group. After adjustment for vascular risk factors, multivariate logistic regression analysis suggested that the MMP-3 5A/6A+5A/5A genotype was an independent risk factor for LAA recurrent ischemic stroke (odds ratio [OR], 1.74; 95% confidence interval [CI], 1.09-2.79, p = 0.021). No significant difference was observed for the MMP-3 serum concentrations between the recurrent group and the first onset group (22.23 ± 8.31 vs. 21.49 ± 7.89 ng/ul, t = 0.88, p = 0.38). The MMP-3 (-1171 5A/6A) polymorphism may contribute to LAA recurrent ischemic stroke susceptibility. Analysis of 5A/6A polymorphism in MMP-3 may identify patients at higher risk for LAA ischemic stroke recurrence, who may be selected for intensive preventive therapy.
authors: a Department of Neurology , Wenzhou Central Hospital & Dingli Clinical Institute of Wenzhou Medical University , Wenzhou , China.
authors: Xiao-Ya
authors: XY
authors: Huang
authors: a Department of Neurology , Wenzhou Central Hospital & Dingli Clinical Institute of Wenzhou Medical University , Wenzhou , China.
authors: Li-Ya
authors: LY
authors: Han
authors: a Department of Neurology , Wenzhou Central Hospital & Dingli Clinical Institute of Wenzhou Medical University , Wenzhou , China.
authors: Xiang-Dong
authors: XD
authors: Huang
authors: a Department of Neurology , Wenzhou Central Hospital & Dingli Clinical Institute of Wenzhou Medical University , Wenzhou , China.
authors: Chao-Hong
authors: CH
authors: Guan
authors: a Department of Neurology , Wenzhou Central Hospital & Dingli Clinical Institute of Wenzhou Medical University , Wenzhou , China.
authors: Xin-Lei
authors: XL
authors: Mao
authors: b Department of Neurology , The First Affiliated Hospital of Wenzhou Medical University , Wenzhou , China.
authors: Zu-Sen
authors: ZS
authors: Ye
mesh_terms: D000368:Aged; D050197:Atherosclerosis / Q000097:blood / Q000235:genetics; D002545:Brain Ischemia / Q000097:blood / Q000235:genetics; D002681:China; D005260:Female; D006801:Humans; D008297:Male; D019278:Matrix Metalloproteinase 3 / Q000097:blood / Q000235:genetics; D008875:Middle Aged; D011110:Polymorphism, Genetic; D020521:Stroke / Q000097:blood / Q000235:genetics
chemical_list: C511768:MMP3 protein, human; D019278:Matrix Metalloproteinase 3
keywords: atherosclerosis; ischemic stroke; matrix metalloproteinase-3; polymorphism; recurrence; stromelysin-1